Role of LDL receptor family members in protecting the vasculature
LDL受体家族成员在保护脉管系统中的作用
基本信息
- 批准号:10532199
- 负责人:
- 金额:$ 77.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-01-01 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAneurysmAortic AneurysmAortic RuptureAwardBiochemicalBlood VesselsCRISPR/Cas technologyCellsCessation of lifeClinical DataCollagenComplexCountryDataDefectDepositionDevelopmentDilatation - actionDiseaseDissectionElastinEventFamily memberGenerationsGenesGeneticGoalsHomeostasisInflammatoryInterventionLDL-Receptor Related Protein 1LigandsLow Density Lipoprotein ReceptorMissense MutationModelingMolecularMusNatureOperative Surgical ProceduresPathway interactionsPatientsPeptide HydrolasesPlayProcessProliferatingProteinsProteomicsResearch PersonnelRoleRuptureSignal TransductionSmooth Muscle MyocytesStructureSymptomsSystemTechnologyVascular Smooth Musclecell growthinhibitorinsightmembermigrationmutantnovel therapeutic interventionreceptorrecruitstructural biologytranscriptome sequencing
项目摘要
The LDL-receptor related protein 1 (LRP1) is a highly efficient endocytic and a signal transducing receptor that
plays an important role in vascular development. By developing a mouse in which LRP1 was genetically
deleted in vascular smooth muscle cells (SMC), we have also discovered that LRP1 protects the vasculature
from the development of aneurysms. Currently, mechanisms by which this occurs are not well understood, but
our studies thus far reveal that LRP1 regulates matrix assembly, TGF signaling, and levels of protease
activity in the vessel wall. Defining the molecular mechanism by which LRP1 regulates these events is one
goal of this Outstanding Investigator Award. The significance of these studies are enhanced by the
identification of patients with aneurysmal disease harboring missense mutations in LRP1. Biochemical
characterization of the functional defects imposed by these mutant receptors will be critical to define the
mechanisms by which LRP1 regulates vessel wall homeostasis, and represents another major goal of our
studies. This will be accomplished by a the generation of mutant LRP1 substituted mice employing the
CRISPR/Cas9 system. LRP1 interacts with over 40 ligands with high affinity, and despite substantial effort,
very little information is available regarding the nature of the receptor/ligand complex. We also propose
strategies to solve this problem using the latest technological advances in structural biology. Closely related in
structure to LRP1 is LRP1B, another receptor that is abundant in SMC and regulates their migration and
proliferation by unknown mechanisms. We propose genetic, proteomic and RNA-seq analysis to identify
mechanisms by which this receptor regulates SMC growth. Together, the studies will define the mechanisms
by which LDL receptor family members protect the vasculature from disease and may identify novel
therapeutic approaches for patients harboring LRP1 missense mutations.
LDL 受体相关蛋白 1 (LRP1) 是一种高效的内吞和信号转导受体,
通过培育出具有 LRP1 基因的小鼠,在血管发育中发挥重要作用。
在血管平滑肌细胞(SMC)中删除LRP1后,我们还发现LRP1可以保护血管系统
目前,这种情况发生的机制尚不清楚,但
迄今为止,我们的研究表明 LRP1 调节基质组装、TGF 信号传导和蛋白酶水平
定义 LRP1 调节这些事件的分子机制是其中之一。
杰出研究者奖的目标增强了这些研究的重要性。
鉴定患有 LRP1 错义突变的动脉瘤疾病患者。
这些突变受体造成的功能缺陷的表征对于定义
LRP1 调节血管壁稳态的机制,代表了我们的另一个主要目标
这将通过使用 LRP1 突变小鼠的产生来完成。
CRISPR/Cas9 系统以高亲和力与 40 多种配体相互作用,尽管付出了巨大的努力,
我们还提出关于受体/配体复合物性质的信息非常少。
利用结构生物学的最新技术进步来解决这个问题的策略。
LRP1 的结构是 LRP1B,它是 SMC 中丰富的另一种受体,调节其迁移和
我们建议通过遗传、蛋白质组和 RNA-seq 分析来识别。
这些研究将共同确定该受体调节 SMC 生长的机制。
LDL 受体家族成员可通过其保护脉管系统免受疾病侵害,并可识别新的
针对携带 LRP1 错义突变的患者的治疗方法。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function.
小鼠主动脉挤压伤:平滑肌细胞增殖和内皮功能的有效体内模型。
- DOI:10.3791/55201
- 发表时间:2017
- 期刊:
- 影响因子:0
- 作者:Yu,Dan;Makkar,George;Sarkar,Rajabrata;Strickland,DudleyK;Monahan,ThomasS
- 通讯作者:Monahan,ThomasS
Current View on the Molecular Mechanisms Underlying Fibrin(ogen)-Dependent Inflammation.
- DOI:10.1055/a-1910-4538
- 发表时间:2022-11
- 期刊:
- 影响因子:6.7
- 作者:
- 通讯作者:
Characterization of interaction between blood coagulation factor VIII and LRP1 suggests dynamic binding by alternating complex contacts.
- DOI:10.1111/jth.15817
- 发表时间:2022-10
- 期刊:
- 影响因子:10.4
- 作者:Chun, Haarin;Kurasawa, James H.;Olivares, Philip;Marakasova, Ekaterina S.;Shestopal, Svetlana A.;Hassink, Gabriela U.;Karnaukhova, Elena;Migliorini, Mary;Obi, Juliet O.;Smith, Ally K.;Wintrode, Patrick L.;Durai, Prasannavenkatesh;Park, Keunwan;Deredge, Daniel;Strickland, Dudley K.;Sarafanov, Andrey G.
- 通讯作者:Sarafanov, Andrey G.
Role of the LDL Receptor-Related Protein 1 in Regulating Protease Activity and Signaling Pathways in the Vasculature.
- DOI:10.2174/1389450119666180511162048
- 发表时间:2018
- 期刊:
- 影响因子:3.2
- 作者:Au DT;Arai AL;Fondrie WE;Muratoglu SC;Strickland DK
- 通讯作者:Strickland DK
Molecular chaperone RAP interacts with LRP1 in a dynamic bivalent mode and enhances folding of ligand-binding regions of other LDLR family receptors.
- DOI:10.1016/j.jbc.2021.100842
- 发表时间:2021-07
- 期刊:
- 影响因子:0
- 作者:Marakasova E;Olivares P;Karnaukhova E;Chun H;Hernandez NE;Kurasawa JH;Hassink GU;Shestopal SA;Strickland DK;Sarafanov AG
- 通讯作者:Sarafanov AG
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dudley K. Strickland其他文献
Dudley K. Strickland的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dudley K. Strickland', 18)}}的其他基金
Upgrading the CVID Biosensor Core Facility with a Biacore 8K instrument
使用 Biacore 8K 仪器升级 CVID 生物传感器核心设施
- 批准号:
10176937 - 财政年份:2021
- 资助金额:
$ 77.25万 - 项目类别:
Role of LDL receptor family members in protecting the vasculature
LDL受体家族成员在保护脉管系统中的作用
- 批准号:
10321556 - 财政年份:2017
- 资助金额:
$ 77.25万 - 项目类别:
Role of LDL receptor family members in protecting the vasculature
LDL受体家族成员在保护脉管系统中的作用
- 批准号:
10078621 - 财政年份:2017
- 资助金额:
$ 77.25万 - 项目类别:
Mechanisms by which LRP1 Protects the Vasculature
LRP1 保护脉管系统的机制
- 批准号:
9002897 - 财政年份:2014
- 资助金额:
$ 77.25万 - 项目类别:
Mechanisms by which LRP1 Protects the Vasculature
LRP1 保护脉管系统的机制
- 批准号:
8722143 - 财政年份:2014
- 资助金额:
$ 77.25万 - 项目类别:
Role of Lipoprotein Receptors in Venous Thrombosis
脂蛋白受体在静脉血栓形成中的作用
- 批准号:
8435382 - 财政年份:2012
- 资助金额:
$ 77.25万 - 项目类别:
Role of Lipoprotein Receptors in Venous Thrombosis
脂蛋白受体在静脉血栓形成中的作用
- 批准号:
8320618 - 财政年份:2012
- 资助金额:
$ 77.25万 - 项目类别:
Role of Lipoprotein Receptors in Venous Thrombosis
脂蛋白受体在静脉血栓形成中的作用
- 批准号:
8814273 - 财政年份:2012
- 资助金额:
$ 77.25万 - 项目类别:
Role of Lipoprotein Receptors in Venous Thrombosis
脂蛋白受体在静脉血栓形成中的作用
- 批准号:
8623147 - 财政年份:2012
- 资助金额:
$ 77.25万 - 项目类别:
相似国自然基金
β-羟基丁酸通过分子伴侣介导的自噬降低巨噬细胞中NLRP3表达在腹主动脉瘤发展中的机制研究
- 批准号:82300536
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PP2A调控内皮细胞EndMT促进腹主动脉瘤发展的机制研究
- 批准号:82370488
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
Tet2缺失介导的不确定潜能的克隆性造血(CHIP)调控NLRP3/IL-1β在腹主动脉瘤发生发展中的作用和机制
- 批准号:82371594
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
丙酮酸脱氢酶激酶4调控血管平滑肌细胞表型转换在主动脉瘤/夹层中的作用及机制
- 批准号:82370485
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
硫化氢调控铁稳态改善色氨酸代谢障碍在腹主动脉瘤中的作用及机制研究
- 批准号:82370476
- 批准年份:2023
- 资助金额:47 万元
- 项目类别:面上项目
相似海外基金
Anti-medin immunotherapy for vascular aging and related dementias
针对血管老化和相关痴呆的抗 Medin 免疫疗法
- 批准号:
10724869 - 财政年份:2023
- 资助金额:
$ 77.25万 - 项目类别:
Chimeric Antigen Receptor (CAR) Directed T-regulatory Cell Therapy for Aortic Aneurysm
嵌合抗原受体 (CAR) 定向 T 调节细胞治疗主动脉瘤
- 批准号:
10375495 - 财政年份:2020
- 资助金额:
$ 77.25万 - 项目类别:
Osteoclastogenic Macrophage Activation in Aortic Aneurysm
主动脉瘤中破骨巨噬细胞的激活
- 批准号:
10002647 - 财政年份:2019
- 资助金额:
$ 77.25万 - 项目类别: